Arix Bioscience

Arix Bioscience is a healthcare and life science startup with a unique proposition of being unconstrained by geographical or developmental boundaries. Founded in 2015 and headquartered in the United Kingdom, the company partners with entrepreneurs to develop game-changing life science innovations. Their ability to access top-notch life science innovation is unmatched, and they aim to create enterprises that center on breakthrough life science discoveries. The company recently secured a significant $21.44M Post-IPO Equity investment on April 4, 2018. This investment signifies a strong backing and confidence in Arix Bioscience's vision and potential within the industry. The absence of specific investors for this investment may indicate that it was a strategic move to further their own objectives rather than being driven by external influence. Arix Bioscience's focus on biotechnology, finance, and healthcare makes them a key player in the intersection of these rapidly evolving sectors.